IDYA

Conviction 81HealthcareScan · Mon, Aug 10, 2026

IDYA$36.77-0.68%

ResistanceSupportVol 14Insider sell

Vol MA14 802.34K

May 11May 28Jun 16Jul 6Jul 23Aug 10

IDEAYA Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.ideayabio.com ↗

Price36.77

Change-0.68%

Gap-0.54%

Rel volume1.44×

Avg volume801.82K

Avg $ vol28.97M

SMA 2036.07

SMA 5034.32

SMA 20032.96

Price vs 50+7.13%

Price vs 200+11.54%

MA stackbullish

50/200 cross—

Supertrendup · 34.19

RSI (14)56

MACD hist-0.06

MACD cross—

Stoch %K / %D71 / 69

ADX (14)15

+DI / −DI19 / 14

RSI divergence—

MACD divergence—

ATR %+3.77%

ADR %3.63%

52w high40.51

52w low22.84

From 52w high-9.23%

Above 52w low+60.99%

New 52w highNo

SqueezeOn · 5d

Bollinger width6.00%

%B0.82

Donchian pos70.95%

Donchian high37.90

Donchian low34.01

AVWAP (52w high)36.66

vs AVWAP high+0.31%

AVWAP (52w low)31.43

vs AVWAP low+16.97%

OBV trendFlat

Chaikin MF (20)-0.02

Today vs 20d1.44×

Avg vol (14d)802.34K

Avg vol (20d)801.82K

Avg $ vol (20d)28.97M

Market cap3.55B

RS 3m (vs SPY)+25.39%

RS 6m (vs SPY)+2.41%

RS line new highNo

Trend template6/8

Technical rank71.6

1 week+3.87%

1 month-0.59%

3 months+29.84%

6 months+14.30%

1 year+64.08%

YTD+8.63%

P/E-31.20

P/B2.96

P/S16.22

P/FCF-48.29

EPS-1.28

Div yield—

ROE-9.48%

ROA-8.68%

Debt/Eq—

Current10.45

EV/EBITDA-20.91

Gross margin—

Net margin-51.99%

Rev growth3024.43%

EPS growth58.58%

Price target51.91

Target upside41.17%

Analyst ratingBuy

Institutional104.81%

Ent. value3.28B

Revenue8.86M

Net income-112.45M

Gross profit—

Free cash flow-73.47M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out87.86M

Employees145

ListedThu, May 23, 2019

Free float87.08M

Float %99.1%

Short interest9.57M

Days to cover8.6d

Short volume82.1%

Squeeze score74 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.22 vs −$1.18

Last surprise-3.4% miss

Setup gradeA

Conviction81 / 100

Pattern quality—

Tech rank71.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance39.40

Support34.29

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IDYA

All disclosures →

No recent disclosed trades by Congress in IDYA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IDYA · 7 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Ruiz Briseno Andres Chief Accounting Officer · Common Stock · 2026-07-07	Exercise	9.55K	$123K	2026-07-07	2026-07-09
Ruiz Briseno Andres Chief Accounting Officer · Common Stock · 2026-07-07	Sell	9.55K	$382K	2026-07-07	2026-07-09
Ruiz Briseno Andres Chief Accounting Officer · Stock Option (Right to Buy) · 2026-07-07	Exercise	9.55K	—	2026-07-07	2026-07-09
Hampton Malcolm Garret Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
MACKEY CATHERINE J Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
Morrison Scott W Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
ROSEN TERRY J Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
Stein Jeffrey Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18
YARNO WENDY L Director · Stock Option (right to buy) · 2026-06-16	Grant	20K	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in IDYA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.